1. 1992

    Began work with Sickle Cell Patients

  2. 1995

    Began Research on Sickle Cell Disease at Harbor UCLA

  3. 1997

    Received funding from NIH for continued research in Sickle Cell Disease

  4. 2000

    Received FDA grant and Founded Emmaus Life Sciences

  5. 2000-2003

    Phase I Clinical trials

  6. 2003-2008

    Phase II Clinical Trials

  7. 2009-2014

    Phase III Clinical Trials

  8. July 7, 2017

    FDA approval for first ever treatment of Sickle Cell Disease in pediatric patients and first treatment for Sickle Cell Disease in 20 years

  9. January 17, 2018

    Availability of Endariā„¢ (L-glutamine oral powder) for Sickle Cell Disease in the United States